Toshiba rolls out ultrasound upgrade

Article

Toshiba American Medical Systems of Tustin, CA, last month introduced the next generation of its mid-range ultrasound scanners at the American College of Cardiology conference in New Orleans. PowerVision 6000edp (expanded digital performance) allows

Toshiba American Medical Systems of Tustin, CA, last month introduced the next generation of its mid-range ultrasound scanners at the American College of Cardiology conference in New Orleans. PowerVision 6000edp (expanded digital performance) allows users to select multifrequency tissue harmonics that best match the size of the patient and acoustic access, and incorporates technological advancements in Doppler performance and color maps for cardiac and vascular applications.

Other technologies available on the system include Toshiba’s version of harmonic imaging, called Flash Echo Imaging, and its latest version of Clear View Tissue Harmonics (CVTH). The company plans to provide the $30,000 PowerVision 6000edp as a free upgrade to facilities that already have PowerVision 6000 installed. Toshiba launched PowerVision 6000 last spring (SCAN 5/27/98).

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.